Update from the Medical Devices Branch Use of market authorisation - - PowerPoint PPT Presentation

Update from the Medical Devices Branch

Use of market authorisation evidence from comparable overseas regulators / assessment bodies for medical devices

Irina Tsyganova Director, Devices Applications and Verification Medical Devices Branch Therapeutic Goods Administration, Department of Health ARCS Conference 22 August 2018

Overview

• Review of Medicines and Medical Devices Regulation recommendations and what

is changing

• Abridgement of TGA conformity assessment

– Examples of the use of overseas reports for requests for abridgement

• Applications for ARTG inclusion

– Preliminary assessments and conformity assessment documents – Examples of the approved overseas regulator conformity assessment documents – Examples of decisions on selecting applications for audit

1

Review of Medicines and Medical Devices Regulation

Recommendations accepted by the Australian Government from the Expert Panel Review of Medicines and Medical Devices Regulation (MMDR) include:

• Better utilisation of marketing approvals of medical devices where the device has

been

• conformity assessed by a body that has been designated to undertake conformity

assessments by a comparable overseas designating authority or

• approved by a comparable overseas national regulatory authority
• TGA retain responsibility for making decisions regarding market authorisation of

therapeutic goods in Australia ! The TGA will continue to assess applications for conformity assessment certificates for some devices and for the inclusion of medical devices in the Australian Register of Therapeutic Goods (ARTG)

2

Overseas documents that TGA will consider

• For the purposes of abridgement of TGA conformity assessments or as the documentation

required for ARTG inclusion applications, TGA will consider documents and/or assessment reports issued by:

• Notified Bodies designated under European Union medical device regulatory frameworks
• United States Food and Drug Administration (FDA)
• Health Canada
• Japanese authorities
• Medical Device Single Audit Program (MDSAP) Auditing Organizations (AO)
• The documentation must be issued for the same medical device as you are applying for

in Australia with:

• the same design
• the same intended purpose and
• intended for the same clinical indications

3

Compliance with the essential principles

! Remember, you still must comply with the essential principles

• All devices supplied in Australia must comply with the Australian essential

principles of safety and performance, including the labelling requirements

• Schedule 1 of the Therapeutic Goods (Medical Device) Regulations 2002
• Compilation No 37, Compilation start date: 1 July 2018

(https://www.legislation.gov.au/Details/F2018C00490), and

• Unincorporated Amendments: Therapeutic Goods (Medical Devices) Amendment

(Implantable Medical Devices) Regulations 2017 (F2017L01692) https://www.legislation.gov.au/Series/F2002B00237)

4

How overseas market authorisation can be used Applying for abridgement

• f TGA

conformity assessment

5

Providing documents in applications for ARTG inclusion

Abridgement of TGA conformity assessment

• Documents should demonstrate that manufacturers’ quality management systems

(QMS) meet certain requirements (against the relevant conformity assessment procedure), and that the devices comply with the relevant essential principles

• An overseas audit report or product evaluation report may contain information

that demonstrates that the requirements are met

• Reports should be relevant to the TGA’s conformity assessment and should

facilitate reduction of the TGA work that must be undertaken on a particular application

6

Example A – use of overseas initial audit report for an application for TGA conformity assessment certificate

• Schedule 3, Part 1 - Full Quality Assurance procedures certificate

– Requires QMS assessment and Design-examination certificates – The manufacturer has an EU Medical Device Directive (MDD) Full Quality Assurance (FQA) audit report – The FQA audit report is an initial audit report that covers the same manufacturing sites and device categories as in the application to the TGA

• Applicant may provide the FQA audit report to the TGA

with the supporting documentation for the application

• If the report is sufficiently detailed, we may be able to

reduce the assessment by undertaking a desktop assessment of the QMS instead of an on-site audit

Example B - use of overseas re-audit report for an application for TGA conformity assessment certificate

• Schedule 3, Part 1 - Full Quality Assurance procedures certificate

– Requires QMS assessment and Design-examination certificates – The manufacturer has an EU Medical Device Directive (MDD) Full Quality Assurance (FQA) audit report – The FQA audit report is a recertification audit report (re-audit) that covers the same manufacturing sites and device categories as in the application to the TGA

• Applicant may provide the FQA audit report (re-audit)

to the TGA with other documentation for the application

• If the report is sufficiently detailed, we may be able to

reduce the assessment by undertaking a desktop assessment of the QMS instead of an on-site audit

8

Example C - assessing substantial change to TGA Production quality assurance certificate

• Manufacturer has a valid TGA conformity assessment

certificate issued under Schedule 3, Part 4 - Production quality assurance certificate and requires assessment of substantial change(s) – The manufacturer has an MDSAP Audit Report for a surveillance audit that includes assessment of the change – Applicant may provide the MDSAP audit report to the TGA with other documentation for the application

• If the report is sufficiently detailed and the change

has been assessed as satisfactory by the AO, we may be able to abridge the assessment

• f the change

9

Applications for ARTG inclusion

• Applications must pass preliminary assessment

‒ Must be made in accordance with a form and manner approved for classification of a medical device ‒ Application fee must be paid ‒ Application must be accompanied by the kind of information prescribed for the application of this classification by legislative instrument and provided in an approved form ‒ For the devices that must have TGA conformity assessment certificate – such certificate is in force ‒ The applicant has certified the section 41FD matters

Therapeutic Goods Act 1989, section 41FDB

10

Application form and manner approved

• Medical Device Applications and IVD Applications must be made electronically via TGA

Business Services client’s portal

• There are separate forms approved for different classifications
• Sponsors must select correct form depending on

the Class of their device

• Sponsors must fill in all relevant fields in the application form
• Manufacturer Evidence ID is one of the mandatory fields in the application form

Paragraph 41FDB(2)(a)

11

Conformity assessment procedures or comparable procedures

• The conformity assessment procedures or comparable procedures set out the requirements

relating to the application of manufacturers’ quality management systems for medical devices and

• ther requirements imposed on manufacturers, specifically in relation to the design and

production of medical devices Conformity assessment documents provided with ARTG inclusion application (Evidence of product assessment) Conformity assessment documents included as Manufacturer Evidence (QMS Certification)

12

Conformity assessment evidence – status quo

• Sponsors must have sufficient information available (or have access to such

information) to substantiate the application by the manufacturer of appropriate conformity assessment procedures to the device they seek pre-market authorisation for:

• Conformity assessment certificates issued by the TGA

(Schedule 3, Therapeutic Goods (Medical Devices) Regulations 2002)

• EC Certificates issued by European Notified Bodies

(Council Directives 93/42/EEC, 90/385/EEC, 98/79/EC)

• Declarations of conformity for Class I/Class 1IVD and for systems and

procedure packs, and ISO 13485 for IVD medical devices

13

What has changed?

• Overseas regulator conformity assessment documents (on its own or in combination with other

documents) that demonstrate requirements comparable to the conformity assessment procedures now also include:

• Certificates issued by Notified Bodies under EU Medical Device Regulation 2017/745 and

IVD Regulation 2017/746 (in addition to current EC Certificates)

• Premarket Approvals (PMA)/510(k) Clearances/De novo summaries issued by US FDA
• Certificates and licences issued under the Canadian Medical Device Regulations
• Pre-market approvals from Japan (issued by the Ministry of Health, Labour and Welfare

(MHLW), Pharmaceutical and Medical Devices Agency (PMDA) or Registered Certified Body (RCB), whichever is relevant)

• Certificates issued under the MDSAP

14

Example A – Medical Device Application for Class Is

• Application for inclusion in the ARTG of Class I medical device

intended to be supplied sterile – The manufacturer has EC Certificate issued by the European Notified Body under EU MDD 93/42/EEC

• Sponsor is required to provide

– Manufacturer Evidence

• EC Certificate issued under either Annex II.3 or Annex V

– Documentation that must be provided with the application for inclusion of the medical device in ARTG

• In this case, no information is required

15

Example B – Medical Device Application for Class IIb

• Application for ARTG inclusion of Class IIb medical device

– The manufacturer has MDSAP Certificate for the QMS and product approvals from FDA and/or Health Canada

• Sponsor is required to provide

– Manufacturer Evidence

• MDSAP Certificate

! The MDSAP certificate must be issued to the manufacturer stated on the labelling and instructions for use as the manufacturer of the kind of device for which application is submitted – Documentation that must be provided with the application for inclusion of the medical device in ARTG

• Health Canada: Medical device licence Class III or
• US FDA: De Novo or 510(k) or PMA

16

Example C – IVD Application for Class 3IVD

• Application for inclusion in the ARTG of Class 3 IVD

– The manufacturer has EC Certificate issued by the European Notified Body under IVDD 98/79/EC

• Sponsor is required to provide

– Manufacturer Evidence  EC Certificate issued under either Annex IV.3

• r Annex VII

– Documentation that must be provided with the application for inclusion of the medical device in ARTG  In case of EC Certificate issued under Annex IV.3 no information is required  In case of EC Certificate issued under Annex VII a Type Examination Certificate issued under Annex V is required

17

‘Use of market authorisation evidence from comparable

• verseas regulators / assessment bodies for medical devices’
• Guidance document available on the TGA website
• Please review

– Table 1 - Evidence that may be used for abridgement of TGA conformity assessment – Table 2 - Information that must accompany ARTG inclusion applications ! The categories of documents included as the Manufacturer Evidence and the Evidence of product review attached with ARTG inclusion application must appear in the same line in Table 2 to be accepted as the information approved to accompany the application

18

Application audit assessments

• Applications for ARTG inclusion of certain medical devices must be selected for audit
• Regulation 5.3
• TGA also may select any ARTG inclusion application for audit where there are any

concerns about the device or information provided in the application

• The level of audit may depend on the category and/or Class of a medical device, and the
• verseas regulator conformity assessment document provided in the application
• Sponsors can submit requests with their applications requiring abridgement of the audit

assessment (including requests to abridge the level of audit if appropriate) – Sponsors are required to provide justification supporting their requests – TGA’s delegate will decide whether such request is appropriate – The guidance on requests for abridged assessment is available on the TGA website

19

Decision on level of audit for Class III/AIMD application

• ARTG inclusion application for Class III or AIMD for which the manufacturer has FDA PMA
• Class III/AIMD ARTG inclusion application that passes preliminary assessment (for which a TGA-

issued conformity assessment certificate is not in force) must be selected for application audit

• Level of application audit:

– Decision on the audit level is based on information provided in the application and/or information

• r signals that the TGA has regarding the device (or similar devices)
• Level 2 audit if:

– device does not appear to be the same as the device specified in the PMA (including differences in the UPI, design, intended purpose or clinical indications) or – there are other signals that raise safety or performance concerns

• Level 1 audit if:

– If none of the criteria for Level 2 audits apply, the application will usually undergo a Level 1 audit

20

Application for Class 3IVD for self-testing or POCT

• ARTG inclusion application for Class 3IVD for self-testing or for point of care testing (POCT) for

which the manufacturer has MDSAP Certificate and FDA 510(k)

• ARTG inclusion application for self-testing or for POCT IVD that passes preliminary assessment

(for which a TGA-issued conformity assessment certificate is not in force) must be selected for application audit

• Level of application audit - technical file review

– TGA request information that demonstrate compliance with the essential principles TGA provide further examples on selecting applications for audit and expected level of audit assessment in Q&A published on TGA website

21

Further information

Therapeutic Goods Act 1989 https://www.legislation.gov.au/Series/C2004A03952 – Chapter 4 – Medical Devices Therapeutic Goods (Medical Devices) Regulations 2002 https://www.legislation.gov.au/Series/F2002B00237

22

23